BioSpace News Archive

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today reported its financial results for the full year ended Dec. 31, 2020 and provided a corporate update.

Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, announced today the publication of new data in the journal CELLS.

Aimmune Therapeutics, a Nestlé Health Science company developing and commercializing treatments for potentially life-threatening food allergies, today announced new clinical data from a pooled analysis of three controlled phase 3 (PALISADE1, RAMSES, ARTEMIS2) and three open-label extension

CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on February 24, 2021 it received a notice from Lung Biotechnology, a United Therapeutics subsidiary

With the advantage of remote access and remote monitoring, patients and physicians alike have been exhibiting a growing preference toward telemedicine.

The growing popularity of customized medicine is reshaping the global compounding pharmacies market outlook.

By 2026, the North America cell line development market size is estimated to be around $2.7 billion, triggered by the escalating demand for COVID-19 treatments that involve monoclonal antibodies.

Break Through Cancer (www.breakthroughcancer.org) today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer.

Yesterday, Novo Nordisk a global healthcare company with Canadian headquarters in Mississauga, and the University of Toronto announced a new research hub at U of T’s Mississauga campus that will bring leading public health experts together to help reduce chronic illnesses across the globe.

Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to join national and international efforts to raise awareness about rare diseases and their impact on patients’ lives this Rare Disease Day, February 28.